Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book examines the regulatory framework for untested and unapproved (off-label) uses of medicines in the EU, UK and USA. While off-label uses may offer hope, they may also expose patients to risks and uncertainties. This work clarifies the regulatory mechanisms and litigation trends concerning off-licence prescriptions in these jurisdictions.
This book examines the regulatory framework for untested and unapproved (off-label) uses of medicines in the EU, UK and USA. While off-label uses may offer hope, they may also expose patients to risks and uncertainties. This work clarifies the regulatory mechanisms and litigation trends concerning off-licence prescriptions in these jurisdictions.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Andrea Parziale is a Marie Sklodowska-Curie Fellow at the Institute for Transnational Legal Research at the Faculty of Law, Maastricht University
Inhaltsangabe
Preface and acknowledgements Introduction 1. Off-label uses of medicines between clinical research and practice 2. The regulation of off-label uses in the EU, EU Member States and UK 3. The US regulation of off-label uses of medicines 4. Litigation trends in the EU, EU Member States and UK 5. Litigation trends in the US 6. The influence of the precautionary principle in the civil litigation on off-label uses 7. Conclusions Index
Preface and acknowledgements Introduction 1. Off-label uses of medicines between clinical research and practice 2. The regulation of off-label uses in the EU, EU Member States and UK 3. The US regulation of off-label uses of medicines 4. Litigation trends in the EU, EU Member States and UK 5. Litigation trends in the US 6. The influence of the precautionary principle in the civil litigation on off-label uses 7. Conclusions Index
Preface and acknowledgements Introduction 1. Off-label uses of medicines between clinical research and practice 2. The regulation of off-label uses in the EU, EU Member States and UK 3. The US regulation of off-label uses of medicines 4. Litigation trends in the EU, EU Member States and UK 5. Litigation trends in the US 6. The influence of the precautionary principle in the civil litigation on off-label uses 7. Conclusions Index
Preface and acknowledgements Introduction 1. Off-label uses of medicines between clinical research and practice 2. The regulation of off-label uses in the EU, EU Member States and UK 3. The US regulation of off-label uses of medicines 4. Litigation trends in the EU, EU Member States and UK 5. Litigation trends in the US 6. The influence of the precautionary principle in the civil litigation on off-label uses 7. Conclusions Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826